OraSure rises as seen benefitting from 23andMe/Regeneron deal

Stock Information for OraSure Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About OraSure Technologies Inc.

OraSure to Participate in Upcoming Investor Conference
OraSure Announces Third Quarter 2025 Financial Results
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
OraSure Announces Second Quarter 2025 Financial Results
OraSure Appoints Anne Messing as Chief Commercial Officer
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
OraSure Launches Novel Blood Collection Device for Proteomic Research

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.